Mario Mandala

Associate professor of Medical Oncology

[Mario Mandala @MandalaMario]

Just published our manuscript on discontinuation of combo immunotherapy in melanoma patients with brain metastases https://t.co/iaeRAaHcBH

[Hussein Tawbi, MD, PhD @HTawbi_MDPhD]

Comprehensive overview of systemic therapy for Melanoma Brain Mets by @MandalaMario #EADO2026, first question by the audience highlights the uncertainties in defining “symptomatic” brain metastases

[OncoDaily @oncodaily]

Updated EORTC Protocol for Sentinel Lymph Node Evaluation in Merkel Cell Carcinoma - Mario Mandalà

@EORTC @MandalaMario

https://t.co/osK1eCtVyK

#OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedTwitter

[Piotr Rutkowski @rutkowskip1972]

https://t.co/Ej62XXrOSG in less then one month unique webinar @MandalaMario @OnkologiaPolska @NIO_PIB #melanoma #skincancer

[Via Medica @ViaMedica_pl]

📢 „Advances in diagnostics and therapy of melanoma and other skin cancers”
📅 19 marca i 14 maja 2026
Zapraszają: prof. dr hab. n. med. Piotr Rutkowski, prof. Mario Mandalà
🤝 Patronat: Akademia Czerniaka, IMI
Bezpłatna rejestracja:
https://t.co/w7cimL5Nme
#melanoma #oncology

[Andrea Boutros @boutrosand]

Amazing discussion about #irAEs #ESMO25 by super @MandalaMario & fantastic @DrJNaidoo early this morning - check it out online on the @myESMO website if you missed it - 👏🏽👏🏽🇮🇹 @ImiItaliano

[Mario Mandala @MandalaMario]

Super interesting, interactive, outstanding meeting on rare toxicities in patients receiving Immunotherapy
A special thant to @DrJNaidoo Jarushka Naidoo for charing the session
Thanks @myESMO for organising such beautiful and engaging meeting

[Mario Mandala @MandalaMario]

Statins to prevent anthracycline-related myocardial toxicity: The jury is still out - PubMed https://t.co/zlaa1eSM9I

[Mario Mandala @MandalaMario]

Incidence and prognosis of cutaneous melanoma in European adolescents and young adults (AYAs): EUROCARE-6 retrospective cohort results - PubMed https://t.co/CgLycXYRwC

[Mario Mandala @MandalaMario]

European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics - Update 2024 - PubMed https://t.co/zYzPnBXf3O

[Mario Mandala @MandalaMario]

European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2024 - PubMed https://t.co/pRFMiN5edk

[Mario Mandala @MandalaMario]

Immunotherapy or targeted therapy with or without stereotactic radiosurgery for patients with brain metastases from melanoma or non-small cell lung cancer - The ETOP 19-21 USZ-STRIKE study - PubMed https://t.co/GjtwPjegiT

[Mario Mandala @MandalaMario]

Clinical validation of droplet digital PCR assays in detecting BRAFV600-mutant circulating tumour DNA as a prognostic biomarker in patients with resected stage III melanoma receiving adjuvant therapy (COMBI-AD): a biomarker analysis from a randomised study https://t.co/7mwT2nwWiL

[Via Medica @ViaMedica_pl]

📢 Warsaw Skin Cancer Conference 2025
📅 3–4.10.2025 | 📍 Warszawa
Pod kierunkiem prof. Piotra Rutkowskiego o czerniaku, nowych terapiach i wyzwaniach w leczeniu nowotworów skóry
👉 https://t.co/1xkhsPSeez
#melanoma #onkologia #WarsawSkinCancer2025

[Fondazione Aiom @AiomFondazione]

Martedì 15 luglio alle 17 vi aspettiamo su #AIOMtv per parlare di eccessiva esposizione al #sole e #prevenzione.

Link alla diretta: https://t.co/Zz0jGMHodG

#fondazioneaiom #oncologia #cancro

[Mario Mandala @MandalaMario]

Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: an international retrospective study - European Journal of Cancer https://t.co/wOEoDVNsnx

[Piotr Rutkowski @rutkowskip1972]

https://t.co/s45PhW0gJd join us for Virtual Meetings on Skin Cancers #melanoma @MandalaMario @NIO_PIB @OnkologiaPolska 6 March and 22 May

[Mario Mandala @MandalaMario]

@ProfGLongMIA @ausoftheyear Congrats Georgina 💫🥂🔝😁

[Mario Mandala @MandalaMario]

@EdWilli63968626 Difficult studies to carry out, most of them academic trials but the only way to understand the best sequence and the role of each treatment IO and RT

[Mario Mandala @MandalaMario]

Understanding timing of SRS and immunotherapy: the right study for the right question in patients with brain metastases from melanoma or non-small cell lung cancer – The ETOP 19-21 USZ-STRIKE study - Lung Cancer https://t.co/NvGmXETOjC

[Mario Mandala @MandalaMario]

Adjuvant pembrolizumab did not have a significant impact on long-term HRQOL compared with placebo in patients with resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): long-term, health-related quality-of-life results https://t.co/yGoh2yicpP